Spire Healthcare Group (LON:SPI) Shares Down 16.3% on Analyst Downgrade

Shares of Spire Healthcare Group plc (LON:SPI) traded down 16.3% on Thursday after Deutsche Bank Aktiengesellschaft lowered their price target on the stock from GBX 320 to GBX 300. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock. Spire Healthcare Group traded as low as GBX 169 ($2.18) and last traded at GBX 188 ($2.43). 4,929,258 shares traded hands during mid-day trading, an increase of 648% from the average session volume of 658,925 shares. The stock had previously closed at GBX 224.50 ($2.90).

Spire Healthcare Group Stock Performance

The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The business has a 50 day simple moving average of GBX 227.28 and a two-hundred day simple moving average of GBX 229.74. The firm has a market cap of £711.58 million, a PE ratio of 25.22, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI) last released its earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, equities research analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.